SYN-Tech Chem & Pharm Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.099x

SYN-Tech Chem & Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has a cash flow conversion efficiency ratio of 0.099x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.05 Million ≈ $8.07 Million USD) by net assets (NT$2.59 Billion ≈ $81.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of SYN-Tech Chem & Pharm Co Ltd (2015–2025)

Cash flow conversion efficiency of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for SYN-Tech Chem & Pharm Co Ltd for real-time trading data and today's change.

SYN-Tech Chem & Pharm Co Ltd Cash Flow Conversion Ratio Explained

SYN-Tech Chem & Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SYN-Tech Chem & Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see 1777 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Panache Digilife Limited
NSE:PANACHE
0.050x
Falco Resources Ltd
V:FPC
-0.005x
Reward Wool Industry Corp
TW:1423
0.004x
Excel Cell Electronic Co Ltd
TW:2483
-0.003x
Top Union Electronics
TWO:6266
0.064x
ADDvise Group B
ST:ADDV-B
0.032x
Graphite One Inc
V:GPH
-0.057x
Singular People S.A.
MC:SNG
0.140x

Annual Cash Flow Conversion Efficiency for SYN-Tech Chem & Pharm Co Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. Review how much free cash does SYN-Tech Chem & Pharm Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$2.59 Billion
≈ $81.61 Million
NT$559.49 Million
≈ $17.63 Million
0.216x -11.18%
2024-12-31 NT$2.56 Billion
≈ $80.66 Million
NT$622.61 Million
≈ $19.62 Million
0.243x +114.86%
2023-12-31 NT$2.32 Billion
≈ $73.01 Million
NT$262.29 Million
≈ $8.26 Million
0.113x -43.27%
2022-12-31 NT$2.20 Billion
≈ $69.29 Million
NT$438.81 Million
≈ $13.83 Million
0.200x +152.09%
2021-12-31 NT$1.98 Billion
≈ $62.49 Million
NT$156.98 Million
≈ $4.95 Million
0.079x -69.24%
2020-12-31 NT$1.24 Billion
≈ $39.08 Million
NT$319.21 Million
≈ $10.06 Million
0.257x +30.86%
2019-12-31 NT$1.16 Billion
≈ $36.55 Million
NT$228.12 Million
≈ $7.19 Million
0.197x +14.63%
2018-12-31 NT$1.10 Billion
≈ $34.62 Million
NT$188.49 Million
≈ $5.94 Million
0.172x +298.39%
2017-12-31 NT$996.24 Million
≈ $31.39 Million
NT$42.89 Million
≈ $1.35 Million
0.043x -81.19%
2016-12-31 NT$1.03 Billion
≈ $32.37 Million
NT$235.26 Million
≈ $7.41 Million
0.229x +48.07%
2015-12-31 NT$969.06 Million
≈ $30.53 Million
NT$149.84 Million
≈ $4.72 Million
0.155x --

About SYN-Tech Chem & Pharm Co Ltd

TWO:1777 Taiwan Biotechnology
Market Cap
$108.60 Million
NT$3.45 Billion TWD
Market Cap Rank
#18708 Global
#1028 in Taiwan
Share Price
NT$77.30
Change (1 day)
+0.13%
52-Week Range
NT$70.30 - NT$78.80
All Time High
NT$108.00
About

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more